THOMAS SCIASCIA

CIK 1229946 · Chief Scientific Officer · last filed 2026-02-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.15M

Companies

2

Total Filings

26

Lifetime Open-Market Net

-$289.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRVI Chief Scientific Officer 221,373 $14.21 $3.15M -$289.6K 18 2026-02-20
PENWEST PHARMACEUTICALS CO (PPCO) Delisted SVP Clin Dev & Reg Aff & CMO 0 $0 8 2010-09-22

Recent Filings · Page 3 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2009-03-09 PENWEST PHARMACEUTICALS CO (PPCO) Delisted Grant (A) $0 EDGAR
2008-06-18 PENWEST PHARMACEUTICALS CO (PPCO) Delisted Grant (A) $0 EDGAR
2008-06-12 PENWEST PHARMACEUTICALS CO (PPCO) Delisted Grant (A) $0 EDGAR
2008-04-07 PENWEST PHARMACEUTICALS CO (PPCO) Delisted Grant (A) $0 EDGAR
2008-03-14 PENWEST PHARMACEUTICALS CO (PPCO) Delisted Grant (A) $0 EDGAR
2007-03-02 PENWEST PHARMACEUTICALS CO (PPCO) Delisted Grant (A) $0 EDGAR
Showing 2126 of 26
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.